PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27983945-9	2016	Memantine significantly attenuated the body weight loss, colon weight, the plasma levels of interleukin-1beta (IL-1beta), interleukin-6 (IL-6), and colon level of tumor necrosis factor-alpha (TNF-alpha) and myeloperoxidase (MPO); as well as macroscopic and microscopic signs of colitis.	Memantine	0-9	myeloperoxidase	Mus musculus	207-222	
27983945-9	2016	Memantine significantly attenuated the body weight loss, colon weight, the plasma levels of interleukin-1beta (IL-1beta), interleukin-6 (IL-6), and colon level of tumor necrosis factor-alpha (TNF-alpha) and myeloperoxidase (MPO); as well as macroscopic and microscopic signs of colitis.	Memantine	0-9	myeloperoxidase	Mus musculus	224-227	
16107786-6	2006	In the memantine group, the numbers of TUNEL+, myeloperoxidase (MPO)+, and OX42+ cells decreased in the periphery of the hematoma.	Memantine	7-16	myeloperoxidase	Mus musculus	47-62	
16107786-6	2006	In the memantine group, the numbers of TUNEL+, myeloperoxidase (MPO)+, and OX42+ cells decreased in the periphery of the hematoma.	Memantine	7-16	myeloperoxidase	Mus musculus	64-67	
24473380-9	2014	RESULTS: Memantine pretreatment improved the LPS-induced ALI lung tissue morphological changes, reduced their lung wet/dry ratio, the levels of TNF-alpha and LDH activity in BALF, and also reduced the MPO and MDA content in the lung tissue.	Memantine	9-18	myeloperoxidase	Mus musculus	201-204